Donazioni 15 September, 2024 – 1 Ottobre, 2024 Sulla raccolta fondi

Antithrombotic Drug Therapy in Cardiovascular Disease

Antithrombotic Drug Therapy in Cardiovascular Disease

Edward F. Plow PHD, Peter Kelly MD (auth.), Arman T. Askari, A. Michael Lincoff (eds.)
Quanto ti piace questo libro?
Qual è la qualità del file?
Scarica il libro per la valutazione della qualità
Qual è la qualità dei file scaricati?

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).

Categorie:
Anno:
2010
Edizione:
1
Casa editrice:
Humana Press
Lingua:
english
Pagine:
475
ISBN 10:
1603272348
ISBN 13:
9781603272346
Collana:
Contemporary Cardiology
File:
PDF, 7.03 MB
IPFS:
CID , CID Blake2b
english, 2010
Leggi Online
La conversione in è in corso
La conversione in non è riuscita

Termini più frequenti